V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10437863 | 10033251 | 1.92 | 49.7 | Disease modification (D) | 2016-05-24 | 2016-05-24 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101416830 |
| 10437866 | 10033252 | 1.59 | 76.2 | 03 | 2016-08-29 | 2016-09-23 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 100540764 |
| 10437872 | 10033253 | 1.73 | 48.8 | Curative (C) | 2017-04-29 | 2017-04-29 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100481627 |
| 10437887 | 10033254 | 1.7 | 67.1 | 03 | 2016-03-06 | 2019-06-03 | Rituximab | N | N | RITUXIMAB | 101535598 |
| 10437915 | 10033255 | 1.72 | 82.5 | Palliative (P) | 2018-08-30 | 2018-09-10 | Docetaxel | 02 | N | DOCETAXEL | 100802695 |
| 10437934 | 10033256 | 1.76 | 79.1 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-21 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 101473322 |
| 10437938 | 10033257 | 1.74 | 77 | Palliative (P) | 2017-12-01 | 2018-01-03 | Rituximab | 02 | null | RITUXIMAB | 101863894 |
| 10437955 | 10033258 | 1.69 | 0 | Curative (C) | 2018-01-15 | 2018-02-10 | Capecitabine | 02 | N | CAPECITABINE | 100145842 |
| 10437964 | 10033259 | 1.75 | 86.1 | Adjuvant (A) | 2019-10-22 | 2019-11-17 | Capecitabine | 02 | N | CAPECITABINE | 101748446 |
| 10437985 | 10033260 | 1.64 | null | Neo-adjuvant (N) | 2020-06-16 | 2020-06-29 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100986559 |
| 10437990 | 10033261 | 1.78 | 56.1 | Adjuvant (A) | 2020-08-21 | 2020-08-22 | IBRUTINIB | 02 | N | IBRUTINIB | 101482709 |
| 10438003 | 10033262 | 1.57 | 44.9 | null | 2021-02-17 | 2021-02-17 | Capecitabine | 99 | null | CAPECITABINE | 100965625 |
| 10438028 | 10033263 | 1.55 | 0 | null | 2022-04-18 | 2022-04-26 | CAPECITABINE + OXALIPLATIN | 02 | null | RITUXIMAB | 101485239 |
| 10438044 | 10033264 | 1.7 | 73 | 03 | 2018-03-18 | 2018-04-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100843877 |
| 10438048 | 10033265 | null | 66.8 | null | 2022-01-29 | 2022-02-08 | Capecitabine + Oxaliplatin 21day | 02 | null | IBRUTINIB | 101770629 |
| 10438049 | 10033266 | 1.82 | 101 | Curative (C) | 2016-10-20 | 2016-11-15 | CAPECITABINE + OXALIPLATIN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100961339 |
| 10438062 | 10033267 | 1.64 | 77.7 | Curative (C) | 2017-06-02 | 2017-06-02 | IBRUTINIB | 02 | N | IBRUTINIB | 101435108 |
| 10438066 | 10033268 | 1.8 | 58.7 | Adjuvant (A) | 2017-11-01 | 2017-11-02 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100324410 |
| 10438068 | 10033269 | 1.57 | 72.85 | null | 2021-11-30 | 2021-11-30 | CAPECITABINE + OXALIPLATIN | 02 | null | PEMBROLIZUMAB | 100943143 |
| 10438079 | 10033270 | 1.73 | 0 | Palliative (P) | 2020-01-26 | 2020-01-27 | Capecitabine | 02 | N | CAPECITABINE | 100514541 |
| 10438124 | 10033271 | 1.72 | 80.5 | Palliative (P) | 2016-05-11 | 2016-05-11 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 100949348 |
| 10438131 | 10033272 | 1.49 | 54.9 | Palliative (P) | 2020-06-21 | 2020-07-04 | Docetaxel | 02 | N | DOCETAXEL | 101315714 |
| 10438166 | 10033273 | 1.78 | 63.2 | Palliative (P) | 2019-01-11 | 2019-02-05 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101438985 |
| 10438179 | 10033274 | 1.75 | 88.1 | Adjuvant (A) | 2020-06-03 | 2020-06-24 | Capecitabine + Oxaliplatin 21day | 02 | N | RITUXIMAB | 101092858 |
| 10438193 | 10033275 | 1.7 | 77.3 | 03 | 2021-03-17 | 2021-03-22 | IBRUTINIB | 02 | N | IBRUTINIB | 101383023 |
| 10438218 | 10033276 | 1.6 | 103.9 | null | 2019-01-20 | 2019-01-25 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100666271 |
| 10438228 | 10033277 | 1.69 | 77.4 | Curative (C) | 2017-09-30 | 2019-08-21 | IBRUTINIB | 02 | N | IBRUTINIB | 100375149 |
| 10438259 | 10033278 | 1.75 | 68.9 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-12 | Capecitabine | 02 | Y | CAPECITABINE | 101666995 |
| 10438266 | 10033279 | 1.8 | 92 | Palliative (P) | 2014-10-07 | 2014-10-07 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100605832 |
| 10438279 | 10033280 | 0 | 78.4 | Palliative (P) | 2018-05-17 | 2018-05-19 | IBRUTINIB | 02 | N | IBRUTINIB | 100041902 |
| 10438288 | 10033281 | 1.63 | 80 | Disease modification (D) | 2017-05-14 | 2017-05-16 | Capecitabine | 02 | N | CAPECITABINE | 101448348 |
| 10438299 | 10033282 | 1.7 | 0 | null | 2018-12-23 | 2019-01-09 | Rituximab | 02 | null | RITUXIMAB | 100770245 |
| 10438312 | 10033283 | 1.6 | 98.1 | Palliative (P) | 2017-10-27 | 2017-11-03 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101868473 |
| 10438344 | 10033284 | 1.64 | 87.5 | Palliative (P) | 2019-07-17 | 2019-08-16 | Capecitabine | 02 | N | CAPECITABINE | 101172263 |
| 10438350 | 10033285 | 1.86 | 44.5 | Adjuvant (A) | 2018-01-28 | 2018-02-13 | Rituximab | 02 | N | RITUXIMAB | 101155044 |
| 10438362 | 10033286 | 1.73 | 0 | Palliative (P) | 2019-05-15 | 2019-05-29 | CAPECITABINE + OXALIPLATIN | 02 | N | RITUXIMAB | 101039707 |
| 10438380 | 10033287 | 1.73 | 81 | null | 2020-08-08 | 2020-09-01 | CAPECITABINE + OXALIPLATIN | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101065529 |
| 10438383 | 10033288 | 1.66 | 85.8 | Curative (C) | 2017-08-08 | 2018-07-25 | PEMBROLIZUMAB | 02 | Y | PEMBROLIZUMAB | 100853516 |
| 10438391 | 10033289 | 1.79 | 77.6 | null | 2019-03-23 | 2019-03-23 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101251147 |
| 10438399 | 10033290 | 1.8 | 65.3 | Palliative (P) | 2017-06-17 | 2017-06-17 | Rituximab | 02 | N | RITUXIMAB | 101100953 |
| 10438415 | 10033291 | 1.7 | 83 | Palliative (P) | 2018-12-29 | 2018-12-29 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101865461 |
| 10438430 | 10033292 | 1.82 | 72 | Adjuvant (A) | 2019-08-26 | 2019-08-26 | Capecitabine | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101797385 |
| 10438439 | 10033293 | 1.68 | 89 | Palliative (P) | 2018-11-28 | 2018-12-12 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100292216 |
| 10438450 | 10033294 | 1.58 | 55.5 | null | 2022-02-16 | 2022-02-16 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101606225 |
| 10438489 | 10033295 | 0 | 65.4 | 03 | 2017-07-22 | 2017-07-22 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101194416 |
| 10438503 | 10033296 | 1.76 | 94.25 | null | 2018-07-29 | 2018-08-02 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100374201 |
| 10438540 | 10033297 | 1.69 | 82.4 | Neo-adjuvant (N) | 2021-04-03 | 2021-04-25 | Capecitabine | 02 | null | CAPECITABINE | 101000395 |
| 10438576 | 10033298 | 1.72 | 57.2 | Adjuvant (A) | 2019-05-10 | 2019-05-10 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101544555 |
| 10438578 | 10033299 | 0 | 76.3 | Curative (C) | 2019-10-22 | 2019-11-10 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 101134086 |
| 10438579 | 10033300 | 1.61 | 76.8 | null | 2018-01-08 | 2018-01-12 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100541572 |